Skip to content

ZIVO BIOSCIENCE, INC.

ZIVO

CIK 0001101026

← back to feed
Revenue (TTM)
$150.53K
+468.6% YoY Q3 Nov 2025
Net Income (TTM)
−$9.15M
−72.1% YoY Q3 Nov 2025
EPS Diluted (TTM)
−$2.49
+8.0% YoY Q3 Nov 2025
Gross Margin
32.3%
Q3 Nov 2025
Operating Margin
-6,058.8%
Q3 Nov 2025
Net Margin
-6,080.8%
Q3 Nov 2025
Free Cash Flow (TTM)
−$8.12M
Q3 Nov 2025
Cash
$1.8M
Q3 Nov 2025
Total Debt
$0
Q3 Nov 2025
Shares Outstanding
3.89M sh
Q3 Nov 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings